At the direction of MLP, Services Provider shall gather, process, fractionate, transport, and market all Hydrocarbon production from the Properties (collectively, the “Marketing Services”). In performing the Marketing Services, Services Provider shall # use commercially reasonable efforts to sell and market production from the Properties for the best available price and # perform such Marketing Services as a Reasonable and Prudent Services Provider in accordance with prevailing industry standards and customs.

“Marketing Authorization” means a marketing authorization for the Product granted by the Regulatory Authority.

Taiwan. Licensee shall assess and discuss in good faith with Licensor as to whether it is commercially reasonable to # terminate, cancel or otherwise deregister the Marketing Authorization granted to CANbridge or its Affiliate by the Taiwan Food and Drug Administration that references PUMA’s Marketing Authorization approved by the FDA for the Product and # register a new Marketing Authorization in Taiwan that references Licensee’s Marketing Approval as approved by the EMA for the Product. If Licensee, in its reasonable discretion, determines that the above (i) and (ii) are not commercially reasonable, then Licensee may maintain the Marketing Authorization granted by the Taiwan Food and Drug Administration that references PUMA’s Marketing Authorization approved by the FDA for the Product.

Hong Kong. Licensee shall assess and discuss in good faith with Licensor as to whether it is commercially reasonable to # terminate, cancel or otherwise deregister the Marketing Authorization granted to CANbridge or its Affiliate by the Pharmacy and Poisons Board of Hong Kong that references PUMA’s Marketing Authorization approved by the FDA for the Product and # register a new Marketing Authorization in Hong Kong that references Licensee’s Marketing Approval as approved by the EMA for the Product. If Licensee, in its reasonable discretion, determines that the above (i) and (ii) are not commercially reasonable, then Licensee may maintain the Marketing Authorization granted by the Pharmacy and Poisons Board of Hong Kong that references PUMA’s Marketing Authorization approved by the FDA for the Product.

“Marketing Authorization Application” means an application for permit, report, or other regulatory submission filed in accordance with the laws or regulations of the relevant Governmental Authorities to obtain a Marketing Authorization.

Initial Marketing Plan for Product within ​ after obtaining Marketing Authorization in the Territory in the Field; and

“Marketing authorization application for the Territory” means the process of reviewing and assessing the dossier to support a medicinal product in view of its marketing which is performed within a legislative framework that defines the requirements necessary for application to the respective regulatory authority. The application dossier for marketing application is called Marketing Authorization Application in the Territory, or simply registration dossier.

the EMA has approved the Company’s Marketing Authorization Application for the testing, manufacturing, marketing and commercial sale of ​; and

“Marketing Authorization Application” means an application or submission for Marketing Authorization of a pharmaceutical product filed with a Regulatory Authority that is the equivalent of an NDA filed pursuant to the United States Food & Drug Act to obtain marketing approval for a pharmaceutical product in a given country or region, as applicable.

“Marketing Authorization” means, in respect of a Final Product, such marketing authorization, approval, license, registration or other authorizations issued by a Regulatory Authority in connection with the placing of that Final Product on the market in the Territory.